MXPA02005465A - Derivados de triazaspiro(5.5)undecano y composiciones farmaceuticas que los comprenden, como un ingrediente activo. - Google Patents
Derivados de triazaspiro(5.5)undecano y composiciones farmaceuticas que los comprenden, como un ingrediente activo.Info
- Publication number
- MXPA02005465A MXPA02005465A MXPA02005465A MXPA02005465A MXPA02005465A MX PA02005465 A MXPA02005465 A MX PA02005465A MX PA02005465 A MXPA02005465 A MX PA02005465A MX PA02005465 A MXPA02005465 A MX PA02005465A MX PA02005465 A MXPA02005465 A MX PA02005465A
- Authority
- MX
- Mexico
- Prior art keywords
- active ingredient
- triazaspiro
- same
- drugs containing
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34496799 | 1999-12-03 | ||
JP2000018673 | 2000-01-27 | ||
JP2000027968 | 2000-02-04 | ||
JP2000147882 | 2000-05-19 | ||
PCT/JP2000/008517 WO2001040227A1 (fr) | 1999-12-03 | 2000-12-01 | Derives triazaspiro[5.5]undecane et medicaments contenant ces derives en tant que principe actif |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02005465A true MXPA02005465A (es) | 2003-10-15 |
Family
ID=27480653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02005465A MXPA02005465A (es) | 1999-12-03 | 2000-12-01 | Derivados de triazaspiro(5.5)undecano y composiciones farmaceuticas que los comprenden, como un ingrediente activo. |
Country Status (18)
Country | Link |
---|---|
US (1) | US7119091B2 (es) |
EP (1) | EP1236726B1 (es) |
JP (1) | JP4721087B2 (es) |
KR (1) | KR100613176B1 (es) |
CN (1) | CN1246321C (es) |
AT (1) | ATE283854T1 (es) |
AU (1) | AU780419C (es) |
BR (1) | BR0016111A (es) |
CA (1) | CA2394679A1 (es) |
DE (1) | DE60016454T2 (es) |
ES (1) | ES2233479T3 (es) |
HU (1) | HUP0300641A2 (es) |
MX (1) | MXPA02005465A (es) |
NO (1) | NO323631B1 (es) |
NZ (1) | NZ519183A (es) |
PT (1) | PT1236726E (es) |
TW (1) | TWI224597B (es) |
WO (1) | WO2001040227A1 (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2441162A1 (en) * | 2001-03-19 | 2002-09-26 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical composition comprising, as an active ingredient, triazaspiro[5.5]undecane derivative |
IL157819A0 (en) | 2001-03-19 | 2004-03-28 | Ono Pharmaceutical Co | Triazaspiro [5.5] undecane dericatives and drugs containing the same as the active ingredient |
CZ2004500A3 (cs) * | 2001-10-23 | 2005-03-16 | Ono Pharmaceutical Co., Ltd. | Léčivo osahující kombinaci triazaspiro[5.5] undekanového derivátu s inhibitorem isozymu 3A4 cytochromu P450 a/nebo inhibitorem P-glykoproteinu |
AU2003211427A1 (en) * | 2002-02-18 | 2003-09-04 | Ishihara Sangyo Kaisha, Ltd. | Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same |
US7064211B2 (en) * | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
EP1541574A4 (en) * | 2002-09-18 | 2007-06-20 | Ono Pharmaceutical Co | TRIAZASPIRO DERIVATIVES 5.5 | UNDECANS AND DRUGS CONTAINING THEM AS AN ACTIVE INGREDIENT |
EP1541573A4 (en) * | 2002-09-18 | 2007-05-02 | Ono Pharmaceutical Co | NEW CRYSTALS OF DERIVATIVE TRIAZASPIRO 5.5 | UNDECANES |
JP4666256B2 (ja) | 2002-12-10 | 2011-04-06 | 小野薬品工業株式会社 | 含窒素複素環化合物およびその医薬用途 |
DE60323133D1 (de) | 2002-12-13 | 2008-10-02 | Smithkline Beecham Corp | Cyclohexylverbindungen als ccr5-antagonisten |
US20060251651A1 (en) * | 2002-12-13 | 2006-11-09 | Ono Pharmaceutical Co., Ltd. | Antagonist and agonist which bind to a strong binding site of chemokine receptor |
TW201018661A (en) * | 2003-03-14 | 2010-05-16 | Ono Pharmaceutical Co | Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient |
EP1619193A4 (en) | 2003-04-18 | 2010-08-11 | Ono Pharmaceutical Co | SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF |
WO2004094424A1 (ja) * | 2003-04-21 | 2004-11-04 | Ono Pharmaceutical Co., Ltd. | 含窒素複素環化合物およびその用途 |
EP1716156A2 (en) | 2004-02-10 | 2006-11-02 | F.Hoffmann-La Roche Ag | Chemokine ccr5 receptor modulators |
PL1761542T3 (pl) * | 2004-06-09 | 2008-06-30 | Hoffmann La Roche | Pochodne oktahydropirolo[3,4-c]pirolu i ich zastosowanie jako środków przeciwwirusowych |
EP1768954A4 (en) * | 2004-06-24 | 2008-05-28 | Incyte Corp | 2-METHYLPROPANAMIDES AND THEIR USE AS PHARMACEUTICALS |
NZ551603A (en) * | 2004-06-24 | 2010-11-26 | Incyte Corp | N-substituted piperidines and their use as pharmaceuticals |
AU2005258248A1 (en) * | 2004-06-24 | 2006-01-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
CA2589565A1 (en) * | 2004-06-24 | 2006-01-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
EP1778229A4 (en) * | 2004-08-10 | 2009-06-17 | Incyte Corp | AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS |
NZ553696A (en) | 2004-09-13 | 2010-02-26 | Ono Pharmaceutical Co | Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
US8110581B2 (en) * | 2004-11-10 | 2012-02-07 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
JP2008521898A (ja) * | 2004-12-01 | 2008-06-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | チプラナビル及びgw873140を共に投与することを含むhiv感染症の治療方法 |
US20060235028A1 (en) * | 2005-04-14 | 2006-10-19 | Li James J | Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
US20110052612A1 (en) | 2005-05-31 | 2011-03-03 | Ono Pharmaceutical Co., Ltd. | Spiropiperidine compound and medicinal use thereof |
EA200870344A1 (ru) | 2006-03-10 | 2009-04-28 | Оно Фармасьютикал Ко., Лтд. | Азотсодержащее гетероциклическое производное и фармацевтическое средство, включающее такое производное в качестве активного ингредиента |
EP2051977A2 (en) * | 2006-07-20 | 2009-04-29 | Amgen Inc. | SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1 |
JO3598B1 (ar) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
GB0625523D0 (en) * | 2006-12-21 | 2007-01-31 | Ge Healthcare Ltd | In vivo imaging agents |
KR20090127298A (ko) | 2007-03-29 | 2009-12-10 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 항바이러스 화합물 |
CL2008001839A1 (es) | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
US7977358B2 (en) * | 2007-07-26 | 2011-07-12 | Hoffmann-La Roche Inc. | Pyrazol derivatives |
JP5637982B2 (ja) | 2008-04-09 | 2014-12-10 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | 脂肪酸アミド加水分解酵素の阻害剤 |
AU2010234445A1 (en) | 2009-04-07 | 2011-11-03 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
EP2417115A4 (en) | 2009-04-07 | 2012-10-31 | Infinity Pharmaceuticals Inc | FATTY ACID AMIDE HYDROLASE INHIBITORS |
IN2012DN00352A (es) * | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
KR101888026B1 (ko) | 2010-02-03 | 2018-08-13 | 인피니티 파마슈티컬스, 인코포레이티드 | 지방산 아미드 하이드롤라제 저해제 |
US10383894B2 (en) * | 2010-03-17 | 2019-08-20 | Lutran Industries, Inc. | Human medicinal treatment using salt of peroxymonosulfuric acid |
ES2616238T3 (es) | 2010-10-06 | 2017-06-12 | Glaxosmithkline Llc, Corporation Service Company | Derivados de bencimidazol como inhibidores de PI3 quinasa |
US10092574B2 (en) | 2012-09-26 | 2018-10-09 | Valorisation-Recherche, Limited Partnership | Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof |
KR102341969B1 (ko) | 2012-12-13 | 2021-12-24 | 다니엘 스캇 마샬 | 자기 분극식 광소자 |
US11084807B2 (en) | 2016-08-18 | 2021-08-10 | Vidac Pharama Ltd. | Piperazine derivatives, pharmaceutical compositions and methods of use thereof |
CN108727400B (zh) * | 2017-05-24 | 2021-07-09 | 四川晶华生物科技有限公司 | 一种治疗肿瘤的化合物 |
CN107216335B (zh) * | 2017-06-29 | 2019-04-30 | 上海药明康德新药开发有限公司 | 一种叔丁基1-(羟甲基)-3-氧杂-9-氮杂螺[5.5]十一烷-9-甲酸基酯制法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS231227B1 (en) | 1982-10-01 | 1984-10-15 | Evzen Kasafirek | 2,5-pierazindion derivatives |
CS260899B1 (en) | 1986-11-07 | 1989-01-12 | Evzen Kasafirek | Remedy for gastrointestinal diseases |
WO1993013101A1 (en) * | 1991-12-27 | 1993-07-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Pyridonecarboxylate compound, pharmaceutical use thereof, and spiro compound |
JPH11512723A (ja) * | 1995-09-29 | 1999-11-02 | イーライ リリー アンド カンパニー | フィブリノゲン依存血小板凝集抑制物質としてのスピロ化合物 |
WO1998025605A1 (en) | 1996-12-13 | 1998-06-18 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
US6288083B1 (en) * | 1998-09-04 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
-
2000
- 2000-12-01 NZ NZ519183A patent/NZ519183A/xx unknown
- 2000-12-01 JP JP2001540982A patent/JP4721087B2/ja not_active Expired - Fee Related
- 2000-12-01 AU AU16506/01A patent/AU780419C/en not_active Ceased
- 2000-12-01 MX MXPA02005465A patent/MXPA02005465A/es active IP Right Grant
- 2000-12-01 TW TW089125555A patent/TWI224597B/zh not_active IP Right Cessation
- 2000-12-01 AT AT00979050T patent/ATE283854T1/de not_active IP Right Cessation
- 2000-12-01 BR BR0016111-0A patent/BR0016111A/pt not_active Application Discontinuation
- 2000-12-01 ES ES00979050T patent/ES2233479T3/es not_active Expired - Lifetime
- 2000-12-01 KR KR1020027007117A patent/KR100613176B1/ko not_active IP Right Cessation
- 2000-12-01 HU HU0300641A patent/HUP0300641A2/hu unknown
- 2000-12-01 CA CA002394679A patent/CA2394679A1/en not_active Abandoned
- 2000-12-01 CN CNB008187703A patent/CN1246321C/zh not_active Expired - Fee Related
- 2000-12-01 DE DE60016454T patent/DE60016454T2/de not_active Expired - Lifetime
- 2000-12-01 US US10/148,382 patent/US7119091B2/en not_active Expired - Fee Related
- 2000-12-01 PT PT00979050T patent/PT1236726E/pt unknown
- 2000-12-01 EP EP00979050A patent/EP1236726B1/en not_active Expired - Lifetime
- 2000-12-01 WO PCT/JP2000/008517 patent/WO2001040227A1/ja active IP Right Grant
-
2002
- 2002-05-31 NO NO20022609A patent/NO323631B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
CN1246321C (zh) | 2006-03-22 |
DE60016454T2 (de) | 2005-08-04 |
NO323631B1 (no) | 2007-06-18 |
NO20022609D0 (no) | 2002-05-31 |
EP1236726B1 (en) | 2004-12-01 |
NO20022609L (no) | 2002-07-26 |
KR100613176B1 (ko) | 2006-08-17 |
AU780419C (en) | 2005-09-29 |
EP1236726A4 (en) | 2003-01-15 |
DE60016454D1 (de) | 2005-01-05 |
CN1433419A (zh) | 2003-07-30 |
ATE283854T1 (de) | 2004-12-15 |
US20040097511A1 (en) | 2004-05-20 |
AU1650601A (en) | 2001-06-12 |
NZ519183A (en) | 2005-02-25 |
JP4721087B2 (ja) | 2011-07-13 |
HUP0300641A2 (hu) | 2003-06-28 |
PT1236726E (pt) | 2005-04-29 |
AU780419B2 (en) | 2005-03-17 |
EP1236726A1 (en) | 2002-09-04 |
BR0016111A (pt) | 2003-03-25 |
CA2394679A1 (en) | 2001-06-07 |
KR20030003218A (ko) | 2003-01-09 |
WO2001040227A1 (fr) | 2001-06-07 |
ES2233479T3 (es) | 2005-06-16 |
TWI224597B (en) | 2004-12-01 |
US7119091B2 (en) | 2006-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU780419C (en) | Triazaspiro(5.5)undecane derivatives and drugs containing the same as the active ingredient | |
IL157819A0 (en) | Triazaspiro [5.5] undecane dericatives and drugs containing the same as the active ingredient | |
DE60023878D1 (de) | Heilmittel und vorbeugung für mit chemokinen verbundenen erkrankungen | |
PT1029853E (pt) | Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos | |
NO972910L (no) | Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister | |
GEP20033029B (en) | Substituted 1,8-Naphthyridin-4(1H)-Ones as Phosphodiesterase 4 Inhibitors | |
AU1247195A (en) | Cyclic amide derivatives as neurokinin a antagonists | |
AU2001275798A1 (en) | 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient | |
GB9322643D0 (en) | Lactam derivatives | |
ZA969621B (en) | Therapeutic compounds | |
GR3036639T3 (en) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist | |
DK0733051T3 (da) | Bicykliske, heterocykliske forbindelser som neurokinin A-antagonister | |
DE69217511D1 (de) | Pyridazindionderivate, ihre Herstellung und Verwendung als Arzneimittel | |
EP1172360A4 (en) | NEUROTROPHIN POTENTIALIZERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |